Matthias Hochadel
Overview
Explore the profile of Matthias Hochadel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
1973
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lange P, Frommeyer G, Kleemann T, Brachmann J, Lugenbiel P, Reif S, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004671
: According to current guidelines, cardiac resynchronisation therapy (CRT) is recommended in patients with significantly impaired left ventricular systolic function and left bundle branch block. However, the decision between pacemaker...
2.
Ten-Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia
Rottner L, Metzner A, Hochadel M, Senges J, Willems S, Ince H, et al.
J Am Heart Assoc
. 2024 Dec;
14(1):e034814.
PMID: 39719410
Background: Catheter ablation is the primary treatment option for idiopathic ventricular tachycardia (VT). It plays a key role in acute therapy of electrical storm, treatment of VTs in patients with...
3.
Brockmuller C, Meid A, Senges J, Hochadel M, Haefeli W, Stoll F
Clin Drug Investig
. 2024 Dec;
45(1):29-43.
PMID: 39666256
Background And Objectives: Oral anticoagulation in patients with atrial fibrillation is crucial to prevent thrombus formation in the heart, a major cause of ischemic stroke. The appropriate dose of direct...
4.
Alonso A, Akin I, Hochadel M, Borggrefe M, Lesch H, Grau A, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597789
Atrial fibrillation (AF) is a major cause of stroke. An individual risk estimation remains challenging, as AF patients with and without cerebrovascular event (CVE) may differ in yet unknown factors...
5.
Alken F, Senges J, Schneider S, Hochadel M, Brachmann J, Kleemann T, et al.
Sci Rep
. 2024 Nov;
14(1):29189.
PMID: 39587151
Resting heart rate (RHR) has prognostic implications in heart failure with reduced ejection fraction, where ≤ 70 bpm is targeted. Whether a RHR > 70 bpm assessed within clinical practice...
6.
Thiele H, Moller J, Henriques J, Bogerd M, Seyfarth M, Burkhoff D, et al.
Lancet
. 2024 Sep;
404(10457):1019-1028.
PMID: 39236726
Background: Percutaneous active mechanical circulatory support (MCS) devices are being increasingly used in the treatment of acute myocardial infarction-related cardiogenic shock (AMICS) despite conflicting evidence regarding their effect on mortality....
7.
Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Massberg S, et al.
Eur Heart J Acute Cardiovasc Care
. 2024 Sep;
13(9):658-661.
PMID: 39217624
Aims: In a recent meta-analysis of randomized controlled trials, routine use of veno-arterial ECMO (VA-ECMO) did not improve outcomes in patients with acute myocardial infarction-related cardiogenic shock (AMI-CS), while a...
8.
Zylla M, Ozdemir B, Hochadel M, Zeymer U, Akin I, Grau A, et al.
Clin Res Cardiol
. 2024 Aug;
114(1):138-149.
PMID: 39115608
Background: Community-based interventions may promote awareness and adherence to atrial fibrillation (AF)-related therapies, potentially reducing adverse events. The ARENA project investigated the health status, therapies and events in AF patients...
9.
Chung D, Hochadel M, Senges J, Kleemann T, Eckardt L, Brachmann J, et al.
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999424
: The number of young patients receiving ICDs or CRT-Ds has been increasing in recent decades and understanding the key characteristics of this special population is paramount to optimized patient...
10.
Zeymer U, Freund A, Hochadel M, Schneider S, Thiele H
Lancet
. 2024 Jun;
403(10443):2487-2488.
PMID: 38851286
No abstract available.